Free Preview of Pricing of Drugs Codeveloped by Federal Laboratories and Private Companies: Hearing Before the Subcommittee on Regulation, Business Opportunities, and Technology of the Commit
Pricing of Drugs Codeveloped by Federal Laboratories and Private Companies: Hearing Before the Subcommittee on Regulation, Business Opportunities, and Technology of the Commit
Earn 58 points and enjoy extra savings with plum+. Learn more
Overview
Appropriate for
Language
English
No. of Pages
248
Publisher:1KG Limited
Shipping dimensions: 9" H x 6" W x 1" L
ISBN: 9781334766749
Life stage: null
You May Also Like
Ratings & Reviews
bvseo_sdk, dw_cartridge, 18.2.0, p_sdk_3.2.0
CLOUD, getReviews, 5ms
reviews, product
bvseo-msg: Unsuccessful GET. status = 'ERROR', msg = 'Not Found.'; Unsuccessful GET. status = 'ERROR', msg = 'Not Found.';
Editorial reviews
Author
Others Also Bought
Choose format
PROMOTION DETAILS
*Valid January 13, 2025 - March 2, 2025 at Canadian stores and at indigo.ca with $30.00 or more purchase of eligible in-stock product(s) in a single transaction before taxes, and after discounts. Not valid on previous purchases or in conjunction with other offers.
Pricing of Drugs Codeveloped by Federal Laboratories and Private Companies: Hearing Before the Subcommittee on Regulation, Business Opportunities, and Technology of the Commit/en-ca/pricing-of-drugs-codeveloped-by-federal-laboratories-and-private-companies-hearing-before-the-subcommittee-on-regulation-business-opportunities-and-technology-of-the-commit/5D7C80F3-4359-406D-AB71-092DAD0B8D15.html5D7C80F3-4359-406D-AB71-092DAD0B8D15
Pricing of Drugs Codeveloped by Federal Laboratories and Private Companies: Hearing Before the Subcommittee on Regulation, Business Opportunities, and Technology of the Commit
Pricing Of Drugs Codeveloped By Federal Laboratories And Private Companies: Hearing Before The Subcommittee On Regulation, Business Opportunities, And Technology Of The Commit
Pricing of Drugs Codeveloped by Federal Laboratories and Private Companies: Hearing Before the Subcommittee on Regulation, Business Opportunities, and Technology of the Committee on Small Business, House of Representatives, One Hundred Third Congress, Fi